Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 2
1952 2
1953 1
1954 4
1955 1
1956 1
1957 1
1958 2
1960 3
1961 2
1962 2
1963 14
1964 35
1965 22
1966 24
1967 23
1968 17
1969 36
1970 35
1971 37
1972 48
1973 67
1974 82
1975 94
1976 106
1977 107
1978 103
1979 126
1980 154
1981 165
1982 139
1983 200
1984 218
1985 210
1986 252
1987 287
1988 268
1989 285
1990 305
1991 315
1992 340
1993 402
1994 400
1995 380
1996 481
1997 445
1998 439
1999 464
2000 494
2001 515
2002 624
2003 642
2004 622
2005 693
2006 736
2007 759
2008 817
2009 856
2010 960
2011 1133
2012 1165
2013 1237
2014 1334
2015 1459
2016 1585
2017 1531
2018 1538
2019 1683
2020 1787
2021 1930
2022 1792
2023 1753
2024 562

Text availability

Article attribute

Article type

Publication date

Search Results

31,690 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement"
Page 1
Acute Myeloid Leukemia: A Review.
Pelcovits A, Niroula R. Pelcovits A, et al. R I Med J (2013). 2020 Apr 1;103(3):38-40. R I Med J (2013). 2020. PMID: 32236160 Free article. Review.
Acute myeloid leukemia (AML) is a malignancy of the stem cell precursors of the myeloid lineage (red blood cells, platelets, and white blood cells other than B and T cells). ...
Acute myeloid leukemia (AML) is a malignancy of the stem cell precursors of the myeloid lineage (red blood cells, platelets, a …
Myeloid Sarcoma: Presentation, Diagnosis, and Treatment.
Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Almond LM, et al. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267. doi: 10.1016/j.clml.2017.02.027. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28342811 Review.
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with acute myeloid leukemia (AML), although in some rare cases it may present in nonleukemic patients. ...
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with acute …
Molecular alterations in acute myeloid leukemia and their clinical and therapeutical implications.
Infante MS, Piris MÁ, Hernández-Rivas JÁ. Infante MS, et al. Med Clin (Barc). 2018 Nov 9;151(9):362-367. doi: 10.1016/j.medcli.2018.05.002. Epub 2018 Jun 9. Med Clin (Barc). 2018. PMID: 29895422 Review. English, Spanish.
Acute myeloid leukaemia is the most common form of acute leukaemia, and its incidence increases with age. ...The identification of recurrent cytogenetic anomalies associated with different patterns of acute myeloid leukaemia clinical presentation has led to the inco …
Acute myeloid leukaemia is the most common form of acute leukaemia, and its incidence increases with age. ...The identification of re …
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.
Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Shallis RM, et al. Blood Rev. 2019 Jul;36:70-87. doi: 10.1016/j.blre.2019.04.005. Epub 2019 Apr 29. Blood Rev. 2019. PMID: 31101526 Review.
Acute myeloid leukemia (AML) is a malignant disorder of the bone marrow which is characterized by the clonal expansion and differentiation arrest of myeloid progenitor cells. ...
Acute myeloid leukemia (AML) is a malignant disorder of the bone marrow which is characterized by the clonal expansion and differenti …
The clinical impact of the molecular landscape of acute myeloid leukemia.
Kayser S, Levis MJ. Kayser S, et al. Haematologica. 2023 Feb 1;108(2):308-320. doi: 10.3324/haematol.2022.280801. Haematologica. 2023. PMID: 36722402 Free PMC article. Review.
Research into the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has led to remarkable advances in our understanding of the disease. ...Despite the progress in unraveling the tumor genome, only a small number of recurrent mutations have been incorporated …
Research into the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has led to remarkable advances in our understandin …
Myeloid sarcoma: An overview.
Ramia de Cap M, Chen W. Ramia de Cap M, et al. Semin Diagn Pathol. 2023 May;40(3):129-139. doi: 10.1053/j.semdp.2023.04.009. Epub 2023 Apr 17. Semin Diagn Pathol. 2023. PMID: 37149396 Review.
Myeloid Sarcoma (MS) is a high grade, hematological malignancy defined as an extramedullary tumor mass of myeloid blasts with or without maturation that effaces tissue architecture. It is a highly heterogenous condition that represents a variety of myeloid …
Myeloid Sarcoma (MS) is a high grade, hematological malignancy defined as an extramedullary tumor mass of myeloid blasts with …
'Acute myeloid leukemia: a comprehensive review and 2016 update'.
De Kouchkovsky I, Abdul-Hay M. De Kouchkovsky I, et al. Blood Cancer J. 2016 Jul 1;6(7):e441. doi: 10.1038/bcj.2016.50. Blood Cancer J. 2016. PMID: 27367478 Free PMC article. Review.
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 000 cases per year in the United States alone. Large chromosomal translocations as well as mutations in the genes involved in hematopoietic proliferation and differentiat …
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 000 cases per year in the Unit …
Acute myeloid leukemia.
Rubnitz JE, Gibson B, Smith FO. Rubnitz JE, et al. Hematol Oncol Clin North Am. 2010 Feb;24(1):35-63. doi: 10.1016/j.hoc.2009.11.008. Hematol Oncol Clin North Am. 2010. PMID: 20113895 Review.
Acute myeloid leukemia (AML) is a heterogeneous group of leukemias that result from clonal transformation of hematopoietic precursors through the acquisition of chromosomal rearrangements and multiple gene mutations. ...
Acute myeloid leukemia (AML) is a heterogeneous group of leukemias that result from clonal transformation of hematopoietic precursors …
Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.
Chen X, Cherian S. Chen X, et al. Clin Lab Med. 2017 Dec;37(4):753-769. doi: 10.1016/j.cll.2017.07.003. Epub 2017 Aug 31. Clin Lab Med. 2017. PMID: 29128067 Review.
Flow cytometry plays an indispensible role in the diagnosis and subclassification of acute myeloid leukemia (AML). Using a multiparametric approach, flow cytometry immunophenotyping has the advantage of efficiency with high sensitivity. ...
Flow cytometry plays an indispensible role in the diagnosis and subclassification of acute myeloid leukemia (AML). Using a multiparam …
Myeloid sarcoma.
Shahin OA, Ravandi F. Shahin OA, et al. Curr Opin Hematol. 2020 Mar;27(2):88-94. doi: 10.1097/MOH.0000000000000571. Curr Opin Hematol. 2020. PMID: 31904666 Review.
The significance of cytogenetic and molecular abnormalities in myeloid sarcoma is not completely established, but testing for targetable mutations on myeloid sarcoma cells is feasible, imperative, and may guide treatment decisions. Outcomes in myeloid sarcoma …
The significance of cytogenetic and molecular abnormalities in myeloid sarcoma is not completely established, but testing for targeta …
31,690 results
You have reached the last available page of results. Please see the User Guide for more information.